Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma
GlobeNewswire, Inc.
BRUSSELS, July 01, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company designed to address rare and urgent conditions, today announced that it has completed the acquisition of exclusive development and...
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
GlobeNewswire, Inc.
BRUSSELS, May 19, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development and...
New Memoranda pave the way for €50 million in investments in local development and public health
Government of Slovenia
SLOVENIA, May 18 - The Memoranda were signed by His Excellency Vegard Kaale, Ambassador of the Kingdom of Norway, Her Excellency Helga Hauksdóttir, Ambassador of Iceland, representing the Donor States, i.e., the Kingdom of Norway, the Principality...
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
GlobeNewswire, Inc.
Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients.
4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner and Tetsu Maruyama as Venture Partner
GlobeNewswire, Inc.
Thera Liechtenstein brings extensive biotech investment and company‑building experience to new role as Partner at 4BIO Capital Tetsu Maruyama, former Head of Drug Discovery at Takeda Pharmaceuticals, appointed as Venture Partner London, United...
ESSEPA research illustrates the current state of safeguarding in university sport
EIN Presswire
The research reveals a paradox: while the frameworks often assume safety, participants on the ground report a fragmented system with unclear reporting and gaps.
European Commission’s Approval of CinnaGen’s Teriparatide Signals New Phase of Global Growth
EIN Presswire
The European Commission’s authorization of Zandoriah®, an osteoporosis medication, marks a significant step in CinnaGen’s journey of international expansion DUBAI, DUBAI, UNITED ARAB EMIRATES, July 3, 2026 /EINPresswire.com/ -- July 02, 2026:...
Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
GlobeNewswire, Inc.
CELEBRATION, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare diseases, announced the company submitted...
AMERICAN SWISS FOUNDATION HOSTS AMBASSADOR FAITH WHITTLESEY LEADERSHIP DINNER IN RÜSCHLIKON, SWITZERLAND
EIN Presswire
RÜSCHLIKON, ZÜRICH, SWITZERLAND, July 2, 2026 /EINPresswire.com/ -- On June 16th, the American Swiss Foundation (ASF) hosted the Ambassador Faith Whittlesey Leadership Award Dinner in Rüschikon, bringing together more than 100 alumni, leaders,...
Remarks by Treasury Secretary Scott Bessent before the American Swiss Foundation
U.S. Department of the Treasury
Good afternoon.
Virella Files European Patent Application for Novel SIRT6 Small-Molecule Activators
EIN Presswire
Liechtenstein-based biotech company reports significant lifespan extension in C. elegans and advances toward preclinical development with CRO partners SCHAAN, LIECHTENSTEIN, April 3, 2026 /EINPresswire.com/ -- Virella Ltd, a European biotech...
AMERICAN SWISS FOUNDATION HOSTS 2026 LEADERSHIP SUMMIT IN RÜSCHLIKON, SWITZERLAND
EIN Presswire
"U.S.–Swiss Leadership in Technological Advancements” RÜSCHLIKON, ZÜRICH, SWITZERLAND, June 26, 2026 /EINPresswire.com/ -- On June 16–17, 2026, the American Swiss Foundation convened its annual Leadership Summit at the Swiss Re Centre for Global...
There is a Missing Link Between Identity Verification and Qualified Signatures in European Onboarding
EIN Presswire
Shufti and Evrotrust partner to combine identity verification and Qualified Electronic Signatures in a single onboarding journey across all 27 EU member states.
European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
GlobeNewswire, Inc.
Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European...
Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
GlobeNewswire, Inc.
New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda® (tovorafenib) represents a rare achievement that reinforces the urgent...
Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
GlobeNewswire, Inc.
First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to anticipated inventory drawdowns and...
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
GlobeNewswire, Inc.
If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on Phase II/III clinical data...
CEO Insight’s Investors Guide Examines Evolving Investment Strategies Across Global Financial Markets
EIN Presswire
Featuring senior industry voices, the issue explores cross-border investment, financial innovation and the growing importance of trust in global markets.
St. Kitts and Nevis enters New Space through historic life sciences mission with Switzerland
EIN Presswire
Caribbean–Swiss partnership launches space biology experiment to advance STEM education, research capacity, and international collaboration.
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
GlobeNewswire, Inc.
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ARS Pharma’s partner, ALK-Abelló A/S, who owns the rights to market EURneffy in the EU, will distribute following expected...
Sign up for:
Health Monitor Liechtenstein
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.